Dingli Xu

5.4k total citations
161 papers, 3.9k citations indexed

About

Dingli Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dingli Xu has authored 161 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cardiology and Cardiovascular Medicine, 56 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dingli Xu's work include Cardiovascular Function and Risk Factors (23 papers), Heart Failure Treatment and Management (19 papers) and Cardiac Valve Diseases and Treatments (16 papers). Dingli Xu is often cited by papers focused on Cardiovascular Function and Risk Factors (23 papers), Heart Failure Treatment and Management (19 papers) and Cardiac Valve Diseases and Treatments (16 papers). Dingli Xu collaborates with scholars based in China, United States and Japan. Dingli Xu's co-authors include Qingchun Zeng, Hao Ren, Wenyan Lai, Weiyi Mai, Qiong Zhan, Xianzhong Meng, Zuheng Liu, Sheng Wang, Robert W. Schrier and M. Ohara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Dingli Xu

154 papers receiving 3.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dingli Xu 1.5k 1.3k 616 487 468 161 3.9k
Κimon Stamatelopoulos 1.5k 1.0× 824 0.6× 396 0.6× 459 0.9× 466 1.0× 166 4.2k
Wei Gao 1.3k 0.9× 1.1k 0.8× 567 0.9× 482 1.0× 284 0.6× 151 3.8k
Jiuchang Zhong 1.8k 1.2× 1.9k 1.4× 514 0.8× 407 0.8× 302 0.6× 135 4.7k
Kenjiro Kikuchi 1.6k 1.1× 1.1k 0.8× 751 1.2× 435 0.9× 281 0.6× 264 4.3k
Jian Zhang 1.7k 1.1× 1.6k 1.2× 511 0.8× 298 0.6× 512 1.1× 228 4.5k
Zuyi Yuan 1.4k 0.9× 1.7k 1.3× 375 0.6× 548 1.1× 665 1.4× 240 5.3k
Dylan Burger 1.3k 0.9× 2.3k 1.8× 398 0.6× 715 1.5× 294 0.6× 125 5.4k
Vanessa Xanthakis 2.6k 1.8× 734 0.6× 352 0.6× 852 1.7× 386 0.8× 124 4.6k
Neeraj Dhaun 1.4k 1.0× 909 0.7× 1.0k 1.7× 1.0k 2.1× 329 0.7× 147 4.8k
Christoph Meier 605 0.4× 1.3k 1.0× 548 0.9× 575 1.2× 665 1.4× 94 5.3k

Countries citing papers authored by Dingli Xu

Since Specialization
Citations

This map shows the geographic impact of Dingli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingli Xu more than expected).

Fields of papers citing papers by Dingli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingli Xu. The network helps show where Dingli Xu may publish in the future.

Co-authorship network of co-authors of Dingli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dingli Xu. A scholar is included among the top collaborators of Dingli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingli Xu. Dingli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hao, Tianyu Xu, Qiming Zhao, et al.. (2025). PINK1 modulates Prdx2 to reduce lipotoxicity‐induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction. Clinical and Translational Medicine. 15(1). e70166–e70166. 2 indexed citations
2.
Ge, Qiang, Dingli Xu, Gang Zhang, et al.. (2025). Double filter noise reduction algorithm optimized by RBF neural network for laser absorption spectroscopy. Infrared Physics & Technology. 145. 105718–105718. 2 indexed citations
3.
Gan, Kaifeng, Zhe Luo, Yujuan Dong, et al.. (2025). Hypoxic niches established via endogenous oxygen production in scaffold under anoxia for enhanced bone regeneration. Regenerative Biomaterials. 12. rbaf070–rbaf070.
4.
Wang, Wen, et al.. (2025). Lipid accumulation product: A novel marker for gout and hyperuricemia. PLoS ONE. 20(5). e0324139–e0324139.
5.
Li, Shunyi, Shunyi Li, Haobin Zhou, et al.. (2025). Long‐Term Estimated Physical Activity Patterns From Youth to Middle Age and Left Ventricular Structure and Function: A 30‐Year Longitudinal Study. Journal of the American Heart Association. 14(19). e041256–e041256.
6.
Huang, Rong, Minhui Xu, Yangchao Chen, et al.. (2025). Interleukin-37 attenuates aortic valve lesions by inhibiting N6-methyladenosine-mediated interleukin-1 receptor-associated kinase M degradation. Cardiovascular Research. 121(3). 492–506. 2 indexed citations
7.
Zhang, Hao, Tianyu Xu, Xiao Wang, et al.. (2024). Vericiguat attenuates doxorubicin-induced cardiotoxicity through the PRKG1/PINK1/STING axis. Translational research. 273. 90–103. 8 indexed citations
8.
Xu, Dingli, et al.. (2024). A new strategy for the treatment of middle ear infection using ciprofloxacin/amoxicillin-loaded ethyl cellulose/polyhydroxybutyrate nanofibers. International Journal of Biological Macromolecules. 269(Pt 1). 131794–131794. 8 indexed citations
9.
Yu, Hao, Qilin Yang, Dongqi An, et al.. (2024). α-Ketoglutarate improves cardiac insufficiency through NAD+-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice. Molecular Medicine. 30(1). 15–15. 31 indexed citations
10.
11.
Ma, Zhuang, Zuheng Liu, Xudong Li, et al.. (2023). Metformin Collaborates with PINK1/Mfn2 Overexpression to Prevent Cardiac Injury by Improving Mitochondrial Function. Biology. 12(4). 582–582. 14 indexed citations
12.
Zhou, Haobin, Hao Zhang, Qiong Zhan, et al.. (2022). Blood Pressure Trajectories in Early Adulthood and Myocardial Structure and Function in Later Life. ESC Heart Failure. 9(2). 1258–1268. 7 indexed citations
13.
An, Qing, Shuwen Su, Yan Tu, et al.. (2021). Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease. 12. 364105306–364105306. 3 indexed citations
14.
Zeng, Qingchun, et al.. (2020). Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation. Therapeutic Advances in Chronic Disease. 11. 1754240844–1754240844. 2 indexed citations
15.
Zhou, Jingmin, Xuejuan Jin, Jun Zhou, et al.. (2020). Digoxin is Associated with Worse Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 7(1). 139–147. 7 indexed citations
16.
Zhu, Yuexin, Huiting Chen, Yang Li, et al.. (2019). Comparative efficacy and safety of antithrombotic therapy for transcatheter aortic valve replacement: a systematic review and network meta-analysis. European Journal of Cardio-Thoracic Surgery. 57(5). 965–976. 7 indexed citations
17.
Jin, Xuejuan, Jun Zhou, Jun Zhou, et al.. (2019). Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry). IJC Heart & Vasculature. 25. 100415–100415. 8 indexed citations
18.
Cai, Xiaoyan, Yingying Li, Liang Su, et al.. (2014). Prehypertension and the risk of stroke. Neurology. 82(13). 1153–1161. 86 indexed citations
19.
Huang, Yuli, Yi Luo, Dingji Zhu, et al.. (2014). Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2120–2125. 20 indexed citations
20.
Huang, Rong, et al.. (2013). Associations of MMP1, 3, 9 and TIMP3 Genes Polymorphism with Isolated Systolic Hypertension in Chinese Han Population. International Journal of Medical Sciences. 10(7). 840–847. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Κimon Stamatelopoulos Breakdown of academic impact, for papers by Wei Gao Breakdown of academic impact, for papers by Jiuchang Zhong Breakdown of academic impact, for papers by Kenjiro Kikuchi Breakdown of academic impact, for papers by Jian Zhang Breakdown of academic impact, for papers by Zuyi Yuan Breakdown of academic impact, for papers by Dylan Burger Breakdown of academic impact, for papers by Vanessa Xanthakis Breakdown of academic impact, for papers by Neeraj Dhaun Breakdown of academic impact, for papers by Christoph Meier
Rankless by CCL
2026